Primary signet ring cell carcinoma of the breast: A rare entity with unique biological behavior—A clinical study based on pure signet ring cell carcinoma cohort
- 1 June 2020
- journal article
- research article
- Published by Elsevier BV in Pathology - Research and Practice
- Vol. 216 (6), 152948
- https://doi.org/10.1016/j.prp.2020.152948
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81702992)
This publication has 31 references indexed in Scilit:
- Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015Annals Of Oncology, 2015
- Colorectal signet-ring cell carcinoma: benefit from adjuvant chemotherapy but a poor prognostic factorInternational Journal of Cancer, 2014
- Pure primary signet ring cell carcinoma breast: A rare cytological diagnosisJournal of Cytology, 2013
- Revised RECIST Guideline Version 1.1: What Oncologists Want to Know and What Radiologists Need to KnowAmerican Journal of Roentgenology, 2010
- Clinicopathologic Features of Gastric Carcinoma with Signet Ring Cell HistologyJournal of Gastrointestinal Surgery, 2010
- Characteristics and prognosis for molecular breast cancer subtypes in Chinese womenJournal of Surgical Oncology, 2009
- A retrospective review with long term follow up of 11,400 cases of pure mucinous breast carcinomaBreast Cancer Research and Treatment, 2007
- Pleomorphic lobular carcinoma in situ of the breast composed almost entirely of signet ring cellsPathology International, 2006
- Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trialThe Lancet, 2002